Summarize N1VO34's latest news Novo Nordisk A/S Class B receives Investment Bank Analyst Rating Update By Investing.com • Oct 02, 2024 ...

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...

Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of ...

The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...

Novo Nordisk receives Investment Bank Analyst Rating Update By Investing.com • Jun 30, 2025 ...

Biocon Ltd. is set to seek regulatory approvals for generic versions of Novo Nordisk's Ozempic and Wegovy, targeting key ...

A new sport-utility vehicle launched by Xiaomi has drawn a rush of first-day orders. The sneaker and athletic apparel company expects the decline in its sales and margins to slow in the current ...

SoftBank's Son Lays Out Vision to Be No. 1 in Artificial Superintelligence SoftBank's investment plans have come under scrutiny as Japan tries to close a deal with the Trump administration. There's a ...

President Donald Trump wants manufacturing jobs to return to the U.S., but it's not as simple as that, Virginia experts say ...

Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, ...